Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

Dalhousie University

$15,000.00

Market Assessment Study of Methods for Controlled Delivery of Polyphosphates for Accelerated Blood Clotting

EF 2024-25

Résumé
Blood clotting is the natural response of the human body to hemorrhage - one of the leading causes of death worldwide. The aim of this study is to develop and deliver to the market a novel superabsorbent hemostatic sponge to increase the chance of survival post injury, by accelerating the clotting process. The present invention is specifically designed to address hemorrhage control in trauma, surgical procedures and additionally for patients on blood thinner medication or with hemophilia. It functions by absorbing large volumes of blood while simultaneously releasing polyphosphate (PP), which accelerates blood clot formation and halts bleeding. The effect of PP is dose-dependent and requires careful, controlled release, which this innovation effectively addresses. The estimated valuation of the bleeding control kit market was $US 4.4 billion in 2023 and is anticipated to expand at a CAGR of 2.9% between 2023 and 2033, totaling $US 5.8 billion by 2033. In order to better understand the market opportunity, using the service of a professional market assessment consulting firm, a market study is proposed here that will provide data, assessment criterion, and industry insights to enable understanding and positioning of Methods for Controlled Delivery of Polyphosphates for Accelerated Blood Clotting in the markets of interest. The study will investigate and report on the market size, market growth drivers and constraints, competitive landscape, opportunities/challenges/barriers to market entry, adoption/commercialization of the subject technology and product positioning in the market.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
602179-2025
Name nom
Adibnia, Vahid V
Department département
Applied Oral Sciences,
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2025
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Market Assessment Study of Methods for Controlled Delivery of Polyphosphates for Accelerated Blood Clotting
Keywords
biomaterials; chitosan; hemostasis; medical devices; polyphosphate; wound management
Application summary
Blood clotting is the natural response of the human body to hemorrhage - one of the leading causes of death worldwide. The aim of this study is to develop and deliver to the market a novel superabsorbent hemostatic sponge to increase the chance of survival post injury, by accelerating the clotting process. The present invention is specifically designed to address hemorrhage control in trauma, surgical procedures and additionally for patients on blood thinner medication or with hemophilia. It functions by absorbing large volumes of blood while simultaneously releasing polyphosphate (PP), which accelerates blood clot formation and halts bleeding. The effect of PP is dose-dependent and requires careful, controlled release, which this innovation effectively addresses. The estimated valuation of the bleeding control kit market was $US 4.4 billion in 2023 and is anticipated to expand at a CAGR of 2.9% between 2023 and 2033, totaling $US 5.8 billion by 2033. In order to better understand the market opportunity, using the service of a professional market assessment consulting firm, a market study is proposed here that will provide data, assessment criterion, and industry insights to enable understanding and positioning of Methods for Controlled Delivery of Polyphosphates for Accelerated Blood Clotting in the markets of interest. The study will investigate and report on the market size, market growth drivers and constraints, competitive landscape, opportunities/challenges/barriers to market entry, adoption/commercialization of the subject technology and product positioning in the market.